Cargando…
let-7 and miR-17 promote self-renewal and drive gefitinib resistance in non-small cell lung cancer
Epidermal growth factor receptor-tyrosinase kinase inhibitor (EGFR-TKI) resistance represents a major obstacle in the therapy of non-small cell lung cancer (NSCLC), and the underlying molecular mechanisms are unknown. In this study, it was found that let-7 family expression was downregulated and miR...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609324/ https://www.ncbi.nlm.nih.gov/pubmed/31233201 http://dx.doi.org/10.3892/or.2019.7197 |